O'Donoghue Stephanie, Earley Bernadette, Johnston Dayle, McCabe Matthew S, Kim Jae Woo, Taylor Jeremy F, Duffy Catherine, Lemon Ken, McMenamy Michael, Cosby S Louise, Morris Derek W, Waters Sinéad M
Animal and Bioscience Research Department, Animal and Grassland Research and Innovation Centre, Teagasc, Grange, Meath, Ireland.
Discipline of Biochemistry, National University of Ireland, Galway, Ireland.
Front Genet. 2023 Feb 17;14:1092877. doi: 10.3389/fgene.2023.1092877. eCollection 2023.
Bovine herpesvirus 1 (BoHV-1), is associated with several clinical syndromes in cattle, among which bovine respiratory disease (BRD) is of particular significance. Despite the importance of the disease, there is a lack of information on the molecular response to infection experimental challenge with BoHV-1. The objective of this study was to investigate the whole-blood transcriptome of dairy calves experimentally challenged with BoHV-1. A secondary objective was to compare the gene expression results between two separate BRD pathogens using data from a similar challenge study with BRSV. Holstein-Friesian calves (mean age (SD) = 149.2 (23.8) days; mean weight (SD) = 174.6 (21.3) kg) were either administered BoHV-1 inoculate (1 × 10/mL × 8.5 mL) ( = 12) or were mock challenged with sterile phosphate buffered saline ( = 6). Clinical signs were recorded daily from day (d) -1 to d 6 (post-challenge), and whole blood was collected in Tempus RNA tubes on d six post-challenge for RNA-sequencing. There were 488 differentially expressed (DE) genes ( < 0.05, False Discovery rate (FDR) < 0.10, fold change ≥2) between the two treatments. Enriched KEGG pathways ( < 0.05, FDR <0.05); included Influenza A, Cytokine-cytokine receptor interaction and NOD-like receptor signalling. Significant gene ontology terms ( < 0.05, FDR <0.05) included defence response to virus and inflammatory response. Genes that are highly DE in key pathways are potential therapeutic targets for the treatment of BoHV-1 infection. A comparison to data from a similar study with BRSV identified both similarities and differences in the immune response to differing BRD pathogens.
牛疱疹病毒1型(BoHV-1)与牛的多种临床综合征有关,其中牛呼吸道疾病(BRD)尤为重要。尽管该疾病很重要,但关于牛对BoHV-1感染实验性攻击的分子反应的信息却很缺乏。本研究的目的是调查经BoHV-1实验性攻击的奶牛犊牛的全血转录组。第二个目的是使用来自与牛呼吸道合胞病毒(BRSV)类似攻击研究的数据,比较两种不同BRD病原体之间的基因表达结果。荷斯坦-弗里生犊牛(平均年龄(标准差)= 149.2(23.8)天;平均体重(标准差)= 174.6(21.3)千克)要么接种BoHV-1(1×10⁷/毫升×8.5毫升)(n = 12),要么用无菌磷酸盐缓冲盐水进行 mock 攻击(n = 6)。从第-1天到攻击后第6天每天记录临床症状,并在攻击后第6天采集全血于Tempus RNA管中用于RNA测序。两种处理之间有488个差异表达(DE)基因(P < 0.05,错误发现率(FDR)< 0.10,变化倍数≥2)。富集的KEGG通路(P < 0.05,FDR < 0.05)包括甲型流感、细胞因子-细胞因子受体相互作用和NOD样受体信号传导。显著的基因本体术语(P < 0.05,FDR < 0.05)包括对病毒的防御反应和炎症反应。关键通路中高度差异表达的基因是治疗BoHV-1感染的潜在治疗靶点。与来自BRSV类似研究的数据比较,确定了对不同BRD病原体的免疫反应中的异同。